ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2179

Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology

Laura Aisenberg1, Irit Rasooly1, Pamela Weiss2, Jon Burnham3 and Anna Costello1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Bryn Mawr, PA

Meeting: ACR Convergence 2024

Keywords: Access to care, Pediatric rheumatology, Quality Indicators, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: In early 2020, much of the country’s pediatric rheumatology practice shifted to a telehealth model secondary to the SARS-CoV-2 pandemic. During this discrete period, new patient evaluations were performed using video visits.  Our objective was to assess the diagnostic concordance between video and in-person evaluations.

Methods: We performed a retrospective cohort study of patients seen for a new patient pediatric rheumatology video evaluation from March 1 to June 30, 2020 at a tertiary academic center. Patients met inclusion criteria if they: 1) were < 21 years old, 2) had not been seen by rheumatology previously, and 3) did not carry a rheumatologic diagnosis. Data extraction included all encounters through May 2024. All data were abstracted by 2 reviewers and adjudicated by a 3rd as needed. The primary outcome was concordance between initial video visit diagnosis and diagnosis received at in person follow up visit with rheumatology.  

Results: 167 patients were evaluated during the study period of whom 111 met inclusion criteria. Of these, 72% (n = 80) had a follow up encounter in the system: 69% of those (n = 55) followed up in Rheumatology (Figure 1). 91% (n = 50) of video visit diagnoses were concordant with in-person diagnosis by Rheumatology.  For each of the 5 patients with non-concordant diagnoses, there was a high suspicion of inflammatory arthritis during the video visit, but each was diagnosed with a more benign, non-rheumatologic cause of pain after in-person assessment (Table 1). There were no unplanned ED visits or hospital admissions following video visits.  Significant, chronic rheumatologic conditions were successfully evaluated via video visit and later confirmed in-person (Table 2). Providers were also able to make more benign diagnoses (n) via telehealth including growing pains (2), extremity color change (4), Periodic Fever Syndrome (11), Amplified Musculoskeletal Pain Syndrome (14), and benign positive ANA (13). 25 patients followed up with providers outside of rheumatology within the hospital system for their presenting symptoms. Diagnoses made by other providers were found to be consistent with the rheumatology video visit in all cases.  

Conclusion: In pediatric rheumatology new patient evaluations, diagnostic concordance between initial video visits and subsequent in person evaluations was high. Providers identified significant rheumatologic conditions accurately without delays in diagnosis or interval disease progression.  In cases of diagnostic discordance, the final diagnosis was less concerning in all cases.  These data suggest that video visits are a safe and effective way to initiate pediatric rheumatology care and improve access. 

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Aisenberg: None; I. Rasooly: None; P. Weiss: Abbvie, 12, Clinical trial site PI, NIH NIMAS, 5, PCORI, 5, Pfizer, 1, Spondylitis Association of America, 5; J. Burnham: None; A. Costello: None.

To cite this abstract in AMA style:

Aisenberg L, Rasooly I, Weiss P, Burnham J, Costello A. Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-diagnostic-concordance-between-telehealth-encounters-and-in-person-follow-up-assessments-in-pediatric-rheumatology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-diagnostic-concordance-between-telehealth-encounters-and-in-person-follow-up-assessments-in-pediatric-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology